Immobilization of α-amylase onto functionalized molybdenum diselenide nanoflowers (MoSe2-NFs) as scaffolds: Characterization, kinetics, and potential applications in starch-based industries.

ABSTRACT

The current study presents the application of molybdenum diselenide nanoflowers (MoSe2-NFs) as an innovative substrate for immobilizing α-amylase by glutaraldehyde activation. This approach results in the development of a nanobiocatalyst that exhibits remarkable advantages compared to a standalone enzyme. Several physical methods, such as fluorescence microscopy, FT-IR, SEM, TEM, XRD, AFM, and Raman spectroscopy, were used to confirm that α-amylase was successfully attached to MoSe2-NFs. By employing the Box-Behnken design of the RSM, the parameters were optimized, resulting in an immobilization efficiency of roughly 87.33%. The immobilized variant of α-amylase demonstrated superior thermostability, pH stability, reusability, and storage stability in comparison to the soluble enzyme. The catalytic activity of α-amylase was highest when immobilized on MoSe2-NFs at the same pH and temperature as the soluble enzyme. However, there was an expansion in the range of parameters in which this activity was observed. Furthermore, the immobilized enzyme exhibited a retention of nearly 80% residual activity following 12 successive reuses. The immobilized enzyme exhibited around 82% residual activity after being stored for 120 days. It is possible that the immobilization process changed the Michaelis-Menten constant, which means that the substrate could no longer reach certain active sites on the enzyme because it had become longer. The study's findings suggest that the α-amylase-MoSe2-NFs system could be useful in industry because it can work in a wider range of temperature and pH conditions. Furthermore, the intrinsic non-toxic characteristics of the matrix, along with its ability to be kept for prolonged periods and recycled, render nano biocatalysts very well-suited for the effective synthesis of maltose in the food and pharmaceutical industries.